Zak Mir talks to Dr Anne Brindley, CEO Nuformix about the pharma development company's moves in the fibrosis and oncology area, and the aftermath of the fund raise in March.
Traders Cafe with Zak Mir: Dr Anne Brindley, CEO Nuformix
Jun 10, 2021Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.